Literature DB >> 22108859

Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.

Prashanth Asuri1, Melissa A Bartel, Tandis Vazin, Jae-Hyung Jang, Tiffany B Wong, David V Schaffer.   

Abstract

Efficient approaches for the precise genetic engineering of human pluripotent stem cells (hPSCs) can enhance both basic and applied stem cell research. Adeno- associated virus (AAV) vectors are of particular interest for their capacity to mediate efficient gene delivery to and gene targeting in various cells. However, natural AAV serotypes offer only modest transduction of human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), which limits their utility for efficiently manipulating the hPSC genome. Directed evolution is a powerful means to generate viral vectors with novel capabilities, and we have applied this approach to create a novel AAV variant with high gene delivery efficiencies (~50%) to hPSCs, which are importantly accompanied by a considerable increase in gene-targeting frequencies, up to 0.12%. While this level is likely sufficient for numerous applications, we also show that the gene-targeting efficiency mediated by an evolved AAV variant can be further enhanced (>1%) in the presence of targeted double- stranded breaks (DSBs) generated by the co-delivery of artificial zinc finger nucleases (ZFNs). Thus, this study demonstrates that under appropriate selective pressures, AAV vectors can be created to mediate efficient gene targeting in hPSCs, alone or in the presence of ZFN- mediated double-stranded DNA breaks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108859      PMCID: PMC3277219          DOI: 10.1038/mt.2011.255

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  51 in total

1.  Transient disruption of autocrine TGF-beta signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells.

Authors:  Xiaolong Fan; Gudrun Valdimarsdottir; Jonas Larsson; Ann Brun; Mattias Magnusson; Sten Eirik Jacobsen; Peter ten Dijke; Stefan Karlsson
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

2.  Directed evolution of adeno-associated virus to an infectious respiratory virus.

Authors:  Katherine J D A Excoffon; James T Koerber; David D Dickey; Matthew Murtha; Shaf Keshavjee; Brian K Kaspar; Joseph Zabner; David V Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

3.  AAV-mediated gene targeting methods for human cells.

Authors:  Iram F Khan; Roli K Hirata; David W Russell
Journal:  Nat Protoc       Date:  2011-03-24       Impact factor: 13.491

4.  Gene targeting in human pluripotent stem cells with adeno-associated virus vectors.

Authors:  Kaoru Mitsui; Keiichiro Suzuki; Emi Aizawa; Eihachiro Kawase; Hirofumi Suemori; Norio Nakatsuji; Kohnosuke Mitani
Journal:  Biochem Biophys Res Commun       Date:  2009-08-18       Impact factor: 3.575

5.  Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Authors:  Albert M Maguire; Katherine A High; Alberto Auricchio; J Fraser Wright; Eric A Pierce; Francesco Testa; Federico Mingozzi; Jeannette L Bennicelli; Gui-shuang Ying; Settimio Rossi; Ann Fulton; Kathleen A Marshall; Sandro Banfi; Daniel C Chung; Jessica I W Morgan; Bernd Hauck; Olga Zelenaia; Xiaosong Zhu; Leslie Raffini; Frauke Coppieters; Elfride De Baere; Kenneth S Shindler; Nicholas J Volpe; Enrico M Surace; Carmela Acerra; Arkady Lyubarsky; T Michael Redmond; Edwin Stone; Junwei Sun; Jennifer Wellman McDonnell; Bart P Leroy; Francesca Simonelli; Jean Bennett
Journal:  Lancet       Date:  2009-10-23       Impact factor: 79.321

6.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.

Authors:  Dirk Hockemeyer; Frank Soldner; Caroline Beard; Qing Gao; Maisam Mitalipova; Russell C DeKelver; George E Katibah; Ranier Amora; Elizabeth A Boydston; Bryan Zeitler; Xiangdong Meng; Jeffrey C Miller; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2009-08-13       Impact factor: 54.908

7.  Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year.

Authors:  Artur V Cideciyan; William W Hauswirth; Tomas S Aleman; Shalesh Kaushal; Sharon B Schwartz; Sanford L Boye; Elizabeth A M Windsor; Thomas J Conlon; Alexander Sumaroka; Ji-Jing Pang; Alejandro J Roman; Barry J Byrne; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

8.  Gene targeting in a HUES line of human embryonic stem cells via electroporation.

Authors:  Katherine M Ruby; Binhai Zheng
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

9.  Two factor reprogramming of human neural stem cells into pluripotency.

Authors:  Mark E Hester; Sungwon Song; Carlos J Miranda; Amy Eagle; Phillip H Schwartz; Brian K Kaspar
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

10.  A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells.

Authors:  Ryan R Klimczak; James T Koerber; Deniz Dalkara; John G Flannery; David V Schaffer
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more
  60 in total

Review 1.  Gene therapy using stem cells.

Authors:  Erin R Burnight; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

Review 2.  Find and replace: editing human genome in pluripotent stem cells.

Authors:  Huize Pan; Weiqi Zhang; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2011-12-15       Impact factor: 14.870

Review 3.  E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.

Authors:  Dirk Grimm; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

4.  Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.

Authors:  Jia Liu; Thomas Gaj; Yifeng Yang; Nan Wang; Sailan Shui; Sojung Kim; Chidananda Nagamangala Kanchiswamy; Jin-Soo Kim; Carlos F Barbas
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

5.  Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease.

Authors:  Christian M Brommel; Ashley L Cooney; Patrick L Sinn
Journal:  Hum Gene Ther       Date:  2020-08-21       Impact factor: 5.695

Review 6.  Genome editing: a robust technology for human stem cells.

Authors:  Arun Pandian Chandrasekaran; Minjung Song; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

7.  Advances in homology directed genetic engineering of human pluripotent and adult stem cells.

Authors:  Kalpith Ramamoorthi; Donald Curtis; Prashanth Asuri
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 8.  Gene therapy for hemophilia: what does the future hold?

Authors:  Bhavya S Doshi; Valder R Arruda
Journal:  Ther Adv Hematol       Date:  2018-08-27

Review 9.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

10.  Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.

Authors:  Michael J Castle; Heikki T Turunen; Luk H Vandenberghe; John H Wolfe
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.